.Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01X_OtherAntineoplasticAgents.L01XX35_Anagrelide.Anagrelide

Information

name:Anagrelide
ATC code:L01XX35
route:oral
n-compartments2

Anagrelide is a phosphodiesterase 3 (PDE3) inhibitor used for the treatment of essential thrombocythemia (ET) to reduce elevated platelet counts and the risk of thrombosis. It is approved and utilized clinically for this indication.

Pharmacokinetics

Pharmacokinetic parameters reported for healthy adults and patients with essential thrombocythemia after oral administration.

References

    Revisions

    Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos